PC diagnosis classification is based on the combination of several indicators, including circulating PSA levels, Gleason Score (GS) and tumour node metastasis (TNM), as well as the ‘in situ’, ‘advanced’ or ‘metastatic’ nature of the tumour (5). This evidence concerns the gene KLK3 and neoplasm.